Oscar Health, Kenvue, Hims & Hers: Health earnings roundup

Most notably, Oscar Health reported a profitable quarter as it saw enrollment figures rise. Kenvue's stock is moving higher Tuesday morning while also announcing plans to layoff 4% of its workforce. Ahead of reporting earnings, Hims & HersBuy TD Bank stock and another bank as they crash further into the abyss. The post Big Bank Bull Run? 2 Canadian Bank Stocks Overdue for a Rally appeared first on The Motley Fool Canada.

Scam alert: Cyber security expert warns of possible e-transfer scam that can cause 'chaos' for victims iShares S&P/TSX Composite Index Fund has more dividend income than the S&P 500. The post Hey, Canadian Investors: You Can Do Better Than the S&P 500. Buy This ETF Instead appeared first on The Motley Fool Canada.In this article, we will take a detailed look at Jim Cramer Says “Hang On To Stocks” and Recommends 10 Stocks to Buy. If you want to skip our detailed analysis and see the top 5 stocks in this list, click Jim Cramer Says “Hang On To Stocks” and Recommends 5 Stocks.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Jefferies downgrades Hims & Hers Health on growth concernsJefferies has downgraded Hims & Hers Health (HIMS) to Hold from Buy, lowering its price target to $15. The analysts behind the call say expectations have now...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

Kenvue to Cut About 4% of Workforce as Services for J&J ExpireKenvue Inc. shares rose after the consumer health company announced plans for a roughly 4% reduction in its global workforce, part of an efficiency plan intended to make it more competitive.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

J&J, Kenvue Told to Pay $45 Million to Baby Powder User’s FamilyJohnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies’ baby powders for giving her a fatal cancer in what was the first verdict against the J&J spinoff in a decade-long litigation over the product.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

Him & Hers Health stock soars on Q1 revenue beat, Q2 guidanceHims & Hers Health (HIMS) shares are surging after Monday's market close, fueled by the company's first quarter earnings beat. The telehealth platform...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

Past time for health minister to hit reset button on Natural Health Product over-regulationThe Hill Times
Source: TheHillTimes - 🏆 11. / 79 Read more »